These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 8664408)
1. Endometrial cancer following breast cancer: Effect of tamoxifen and castration by radiotherapy. Sasco AJ; Chaplain G; Amoros E; Saez S Epidemiology; 1996 Jan; 7(1):9-13. PubMed ID: 8664408 [TBL] [Abstract][Full Text] [Related]
2. Iatrogenic risks of endometrial carcinoma after treatment for breast cancer in a large French case-control study. Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC). Mignotte H; Lasset C; Bonadona V; Lesur A; Luporsi E; Rodier JF; Cutuli B; Lasry S; Mauriac L; Granon C; Kerr C; Giard S; Hill C; de Lafontan B; de Gislain C; D'Anjou J; Fondrinier E; Lefeuvre C; Parache RM; Chauvin F Int J Cancer; 1998 May; 76(3):325-30. PubMed ID: 9579567 [TBL] [Abstract][Full Text] [Related]
3. A retrospective study of tamoxifen and endometrial cancer in breast cancer patients. Robinson DC; Bloss JD; Schiano MA Gynecol Oncol; 1995 Nov; 59(2):186-90. PubMed ID: 7590470 [TBL] [Abstract][Full Text] [Related]
4. Population-based study of tamoxifen therapy and subsequent ovarian, endometrial, and breast cancers. Cook LS; Weiss NS; Schwartz SM; White E; McKnight B; Moore DE; Daling JR J Natl Cancer Inst; 1995 Sep; 87(18):1359-64. PubMed ID: 7658496 [TBL] [Abstract][Full Text] [Related]
5. Endometrial cancer survival after breast cancer in relation to tamoxifen treatment: pooled results from three countries. Jones ME; van Leeuwen FE; Hoogendoorn WE; Mourits MJ; Hollema H; van Boven H; Press MF; Bernstein L; Swerdlow AJ Breast Cancer Res; 2012 Jun; 14(3):R91. PubMed ID: 22691381 [TBL] [Abstract][Full Text] [Related]
7. Tamoxifen therapy for breast cancer and endometrial cancer risk. Bernstein L; Deapen D; Cerhan JR; Schwartz SM; Liff J; McGann-Maloney E; Perlman JA; Ford L J Natl Cancer Inst; 1999 Oct; 91(19):1654-62. PubMed ID: 10511593 [TBL] [Abstract][Full Text] [Related]
8. Second cancers after adjuvant tamoxifen therapy for breast cancer in Japan. Matsuyama Y; Tominaga T; Nomura Y; Koyama H; Kimura M; Sano M; Miura S; Takashima S; Mitsuyama S; Ueo H; Ohashi Y Ann Oncol; 2000 Dec; 11(12):1537-43. PubMed ID: 11205460 [TBL] [Abstract][Full Text] [Related]
9. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study. Swerdlow AJ; Jones ME; J Natl Cancer Inst; 2005 Mar; 97(5):375-84. PubMed ID: 15741574 [TBL] [Abstract][Full Text] [Related]
10. Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. Fisher B; Costantino JP; Redmond CK; Fisher ER; Wickerham DL; Cronin WM J Natl Cancer Inst; 1994 Apr; 86(7):527-37. PubMed ID: 8133536 [TBL] [Abstract][Full Text] [Related]
11. Endometrial adenosarcoma with adjuvant tamoxifen therapy for primary breast carcinoma. Jagavkar RS; Shakespeare TP; Stevens MJ Australas Radiol; 1998 May; 42(2):157-8. PubMed ID: 9599835 [No Abstract] [Full Text] [Related]
12. Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen. Bergman L; Beelen ML; Gallee MP; Hollema H; Benraadt J; van Leeuwen FE Lancet; 2000 Sep; 356(9233):881-7. PubMed ID: 11036892 [TBL] [Abstract][Full Text] [Related]
13. The incidence of subsequent endometrial carcinoma with tamoxifen use in patients with primary breast carcinoma. Katase K; Sugiyama Y; Hasumi K; Yoshimoto M; Kasumi F Cancer; 1998 May; 82(9):1698-703. PubMed ID: 9576291 [TBL] [Abstract][Full Text] [Related]
14. Endometrial and other primary cancers after tamoxifen treatment of breast cancer -- results of retrospective cohort study. Ursic Vrscaj M; Kovacic J; Bebar S; Djurisic A; Fras PA; Robic V Eur J Obstet Gynecol Reprod Biol; 2001 Mar; 95(1):105-10. PubMed ID: 11267730 [TBL] [Abstract][Full Text] [Related]
15. Secretory endometrial adenocarcinoma in a tamoxifen user with breast cancer after menopause. Wu CJ; Peng YJ; Yu MH; Chen CH Taiwan J Obstet Gynecol; 2007 Mar; 46(1):88-90. PubMed ID: 17389201 [No Abstract] [Full Text] [Related]
16. Tamoxifen mediated human endometrial carcinogenesis may not involve estrogenic pathways: a preliminary note. Kuwashima Y; Kurosumi M; Kobayashi Y; Tanuma J; Suemasu K; Higashi Y; Kasamatsu T; Shiromizu K; Matsuzawa M; Kishi K Anticancer Res; 1996; 16(5A):2993-6. PubMed ID: 8917418 [TBL] [Abstract][Full Text] [Related]
17. Detection of endometrial cancer in asymptomatic postmenopausal breast cancer patient treated with tamoxifen: a case report. Sinawat S; Chiyabutra T; Kleabkaew P J Med Assoc Thai; 2001 Jul; 84(7):1033-6. PubMed ID: 11759963 [TBL] [Abstract][Full Text] [Related]
18. Endometrial cancer after tamoxifen treatment: a descriptive study of 25 breast cancer patients who subsequently developed endometrial cancer. Peters-Engl C; Medl M; Danmayr E; Mirau M; Alth G; Leodolter S Anticancer Res; 1996; 16(5B):3241-6. PubMed ID: 8920798 [TBL] [Abstract][Full Text] [Related]
19. Endometrial carcinoma following treatment for breast carcinoma in a Nigerian female. A case report and review of the literature. Abudu EK; Musa O; Adefuye PO; Abdul Kareem FB; Agboola AO; Banjo AA Niger Postgrad Med J; 2007 Dec; 14(4):355-7. PubMed ID: 18163149 [TBL] [Abstract][Full Text] [Related]
20. Iatrogenic endometrial megapolyps in women with breast carcinoma. Berezowsky J; Chalvardjian A; Murray D Obstet Gynecol; 1994 Oct; 84(4 Pt 2):727-30. PubMed ID: 9205466 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]